Clinical Trial Update: Effect of Cyclosporine Drug Interaction on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers. Drug-Drug Interaction 2 (DDI2) Study [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study evaluating how cyclosporine affects the absorption, metabolism, and elimination of CHF6001 in healthy volunteers; COPD is th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CHF6001
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED